Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.78 EUR | +0.77% | -2.34% | +0.42% |
08/05 | Transcript : Lenzing Aktiengesellschaft, Q1 2024 Earnings Call, May 08, 2024 | |
03/05 | Lenzing Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.42% | 150.33Cr | - | ||
+17.88% | 542.55Cr | C | ||
+1.32% | 506.39Cr | C- | ||
-0.06% | 369.02Cr | C | ||
+4.64% | 221.96Cr | - | - | |
+13.92% | 182.95Cr | B+ | ||
-6.33% | 100.77Cr | - | D+ | |
+4.49% | 105.35Cr | - | ||
+25.27% | 78Cr | - | - | |
-23.02% | 47Cr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LNZ Stock
- LEN Stock
- Ratings Lenzing AG